Skip to Main Content

Paper Details

COVID-19-neutralizing antibodies predict disease severity and survival.
Cell
494
2021
COVID-19, Coronavirus disease 2019, D614G, IgG, RBD, SARS-, SARS-CoV-2, WIV1, WIV1-CoV, anti-, anti-RBD immunoglobulin G, bat, coronavirus pandemics, lymphopenia, patient, patients
Author NameAffiliation
Wilfredo F Garcia-BeltranMassachusetts General Hospital
Galit AlterRagon Institute of MGH
Richelle C CharlesMassachusetts General Hospital
Jochen K LennerzMassachusetts General Hospital
Anthony J IafrateMassachusetts General Hospital
  • 1 - 5

Datasets

Release 1.2